• 1
    Doyon J. Motor sequence learning and movement disorders. Curr Opin Neurol 2008;21:478-483.
  • 2
    Siegert JS, Taylor KD, Weatherall M, Abernethy DA. Is implicit sequence learning impaired in Parkinson's disease? A meta-analysis. Neuropsychology 2006;20:490-495.
  • 3
    Marinelli L, Crupi D, Di Rocco A, et al. Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord 2009;15:6-11.
  • 4
    Mochizuki-Kawai H, Kawamura M, Hasegawa Y, et al. Deficits in long-term retention of learned motor skills in patients with cortical or subcortical degeneration. Neuropsychologia 2004;42:1858-1863.
  • 5
    Muslimovic D, Post B, Speelman JK, Schmand B. Motor procedural learning in Parkinson's disease. Brain 2007;130:2887-2897.
  • 6
    Ghilardi MF, Feigin AS, Battaglia F, et al. L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease. Parkinsonism Relat Disord 2007;13:146-151.
  • 7
    Shiner T, Seymour B, Wunderlich K, et al. Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease. Brain 2012;135:1871-1883.
  • 8
    Feigin A, Ghilardi MF, Carbon M, et al. Effects of levodopa on motor sequence learning in Parkinson's disease. Neurology 2003;60:1744-1749.
  • 9
    Tremblay PL, Bedard MA, Langlois D, Blanchet PJ, Lemay M, Parent M. Movement chunking during sequence learning is a dopamine-dependent process: a study conducted in Parkinson's disease. Exp Brain Res 2010;2005:375-385.
  • 10
    Shohamy D, Myers CE, Geghman KD, Sage J, Gluck MA. L-Dopa impairs learning, but spares generalization, in Parkinson's disease. Neuropsychologia 2006;44:774-784.
  • 11
    Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001;11:1136-1143.
  • 12
    Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000;38:596-612.
  • 13
    Graef S, Biele G, Krugel LK, et al. Differential influence of levodopa on reward-based learning in Parkinson's disease. Front Hum Neurosci. 2010;4:1-13.
  • 14
    Marzinzik F, Wotka J, Wahl M, Krugel LK, Kordsachia C, Klostermann F. Modulation of habit formation by levodopa in Parkinson's disease. PLoS One 2011;6:e27695.
  • 15
    Frank MJ, Seeberger LC, O'Reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004;306:1940-1943.
  • 16
    Beeler JA, Cao ZF, Kheirbek MA, et al. Dopamine-dependent motor learning: insight into levodopa's long duration response. Ann Neurol 2010;67:639-647.
  • 17
    Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
  • 18
    Nutt JG, Lea ES, Van Houten L, Schuff RA, Sexton GJ. Determinants of tapping speed in normal control subjects and subjects with Parkinson's disease: differing effects of brief and continued practice. Mov Disord 2000;15:843-849.
  • 19
    Nutt JG, Carter JH, Lea ES, Sexton GJ. Evolution of the response to levodopa during the first 4 years of therapy. Ann Neurol 2002;51:686-693.
  • 20
    Jessop RT, Christopher Horowicz C, Dibble LE. Motor learning and Parkinson disease: refinement of movement velocity and endpoint excursion in a limits of stability balance task. Neurorehabil Neural Repair 2006;20:459.
  • 21
    Agostino R, Sanes JN, Hallett M. Motor skill learning in Parkinson's disease. J Neurol Sci 1996;139:218-226.
  • 22
    Harrington DL, Haaland KY, Yeo RA, Marder E. Procedural memory in Parkinson's disease: impaired motor but not visuoperceptual learning. J Clin Exp Neuropsychol 1990;12:323-339.
  • 23
    Schnider A, Gutbrod K, Hess CW. Motion imagery in Parkinson's disease. Brain 1995;118:485-493.
  • 24
    Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
  • 25
    Hardin JW, Hilbe JM. Generalized Estimating Equations. Boca Raton, FL: Chapman & Hall/CRC; 2003.
  • 26
    Ghilardi MF, Eidelberg D, Silvestri G, Ghez C. The differential effect of PD and normal aging on early explicit sequence learning. Neurology 2003;60:1313-1319.
  • 27
    Schmidt RA, Wrisberg CA. Motor Learning and Performance With Web Study Guide: A Situation-Based Learning Approach. 4th ed. Champaign IL: Human Kinetics; 2007.
  • 28
    Kwak Y, Muller M, Bohnen NI, Dayalu P, Seidler RD. Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease. J Neurophysiol 2010;103:942-949.
  • 29
    Kwak Y, Muller M, Bohnen NI, Dayalu P, Seidler RD. L-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease. Behav Brain Res 2012;230:116-124.
  • 30
    Moustafa AA, Sherman SJ, Frank MJ. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism. Neuropsychologia 2008;46:3144-3156.
  • 31
    Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW. L-DOPA disrupts activity in the nucleus accumbens during reversal learning in PD. Neuropsychopharmacology 2007;32:180-189.
  • 32
    Gotham AM, Brown RG, Marsden CD. Frontal cognitive function in patients with PD on and off levodopa. Brain 1988;111:299-321.
  • 33
    Kulsievsky J. Role of dopamine in learning and memory implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging 2000;16:365-379.
  • 34
    Beeler J. Preservation of function in Parkinson's disease: what's learning got to do with it? Brain Res 2011;1423:96-113.
  • 35
    Dowd E, Dunnett SB. Movement without dopamine: striatal dopamine is required to maintain but not to perform learned actions. Biochem Soc Trans 2007;35:428-432.